Literature DB >> 33489701

Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts.

Yukiko Taga1, Yoshitsugu Chigusa1, Sachiko Minamiguchi2, Aki Kido3, Naoki Horikawa1, Akihito Horie1, Junzo Hamanishi1, Eiji Kondoh1, Masaki Mandai1, Ken Yamaguchi1.   

Abstract

Ovarian seromucinous carcinoma (SMC) is an uncommon neoplasia and is composed predominantly of serous and endocervical-type mucinous epithelium. Due to its low frequency and difficult diagnosis, the natural history, characteristic imaging findings, and pathological features of SMC have not been adequately described in the literature thus far. We herein report three cases of ovarian SMC along with magnetic resonance imaging (MRI) findings. The diagnosis of SMC was made after staging laparotomy in all cases, and systemic chemotherapy was performed in two cases. No recurrence was observed in any of the cases. The MRI findings in SMC were so varied that characteristic imaging features useful for diagnosis were not found. In two cases, MRI suggested endometriotic cysts, and endometriosis and seromucinous borderline tumors (SMBTs) were detected concurrently in all cases by histological examination. Thus, it was suggested that SMC develops in multiple stages via endometriosis and SMBT. The cooccurrence of endometriosis and SMBT could also make the diagnosis of SMC more convincing. © The Japan Society of Clinical Oncology 2020.

Entities:  

Keywords:  Endometrioid carcinoma; Endometriosis; Seromucinous borderline tumor; Seromucinous carcinoma

Year:  2020        PMID: 33489701      PMCID: PMC7797404          DOI: 10.1007/s13691-020-00447-x

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  10 in total

1.  Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.

Authors:  Jennifer Taylor; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

Review 2.  The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

3.  Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.

Authors:  Lluis Catasús; Elena Bussaglia; Ingrid Rodrguez; Alberto Gallardo; Cristina Pons; Julie A Irving; Jaime Prat
Journal:  Hum Pathol       Date:  2004-11       Impact factor: 3.466

4.  Newly Categorized Seromucinous Tumor of the Ovary: Magnetic Resonance Imaging Findings.

Authors:  Jin Woo Han; Kyeong Ah Kim; Hye Yoon Chang; Jeong Woo Kim; Yang Shin Park; Jongmee Lee; Jae Woong Choi; Chang Hee Lee; Cheol Min Park
Journal:  J Comput Assist Tomogr       Date:  2019 Jan/Feb       Impact factor: 1.826

5.  Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour.

Authors:  Yasuhisa Kurata; Aki Kido; Yusaku Moribata; Kyoko Kameyama; Yuki Himoto; Sachiko Minamiguchi; Ikuo Konishi; Kaori Togashi
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

6.  Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.

Authors:  Peter F Rambau; John B McIntyre; Jennifer Taylor; Sandra Lee; Travis Ogilvie; Anna Sienko; Don Morris; Máire A Duggan; W Glenn McCluggage; Martin Köbel
Journal:  Am J Surg Pathol       Date:  2017-05       Impact factor: 6.394

7.  Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.

Authors:  Chen Hsuan Wu; Tsui-Lien Mao; Russell Vang; Ayse Ayhan; Tian-Li Wang; Robert J Kurman; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2012-07       Impact factor: 2.762

8.  ARID1A mutations in endometriosis-associated ovarian carcinomas.

Authors:  Kimberly C Wiegand; Sohrab P Shah; Osama M Al-Agha; Yongjun Zhao; Kane Tse; Thomas Zeng; Janine Senz; Melissa K McConechy; Michael S Anglesio; Steve E Kalloger; Winnie Yang; Alireza Heravi-Moussavi; Ryan Giuliany; Christine Chow; John Fee; Abdalnasser Zayed; Leah Prentice; Nataliya Melnyk; Gulisa Turashvili; Allen D Delaney; Jason Madore; Stephen Yip; Andrew W McPherson; Gavin Ha; Lynda Bell; Sian Fereday; Angela Tam; Laura Galletta; Patricia N Tonin; Diane Provencher; Dianne Miller; Steven J M Jones; Richard A Moore; Gregg B Morin; Arusha Oloumi; Niki Boyd; Samuel A Aparicio; Ie-Ming Shih; Anne-Marie Mes-Masson; David D Bowtell; Martin Hirst; Blake Gilks; Marco A Marra; David G Huntsman
Journal:  N Engl J Med       Date:  2010-09-08       Impact factor: 91.245

Review 9.  Endometriosis-associated ovarian neoplasia.

Authors:  Xavier Matias-Guiu; Colin J R Stewart
Journal:  Pathology       Date:  2017-12-11       Impact factor: 5.306

Review 10.  Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues.

Authors:  Michiko Nagamine; Yoshiki Mikami
Journal:  Diagnostics (Basel)       Date:  2020-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.